Drug patents …
… from Kazakhstan to Kalamazoo
Anticipate generic drug launch
Proactively manage your pharmacy inventory
Manage your formulary budget
Find generic entry opportunities
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
|Title:||Phosphate-binding polymers for oral administration|
|Abstract:||Phosphate-binding polymers are provided for removing phosphate from the gastrointestinal tract. The polymers are orally administered, and are useful for the treatment of hyperphosphatemia.|
|Inventor(s):||Holmes-Farley; Stephen Randall (Arlington, MA), Manderville, III; W. Harry (Lynnfield, MA), Whitesides; George M. (Newton, MA)|
|Assignee:||Genzyme Corporation (Cambridge, MA)|
Patent Claim Types:|
see list of patent claims
|Composition; Compound; Dosage form; Use;|
Back Citations: 74th percentile
Forward Citations: 2nd percentile
|Patent Number||Expiration Date|
|7,014,846||March 21, 2014|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|European Patent Office||1133989||► subscribe|
|European Patent Office||1676581||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.